APR 14, 2015 10:22 AM PDT

New Cancer Drug Could Result from 6 Molecules That Block HuR

WRITTEN BY: Will Hector
Scientists have found six molecules that block HuR, an "oncoprotein" linked to cancer that was thought to be "undruggable."

The findings could lead to a new class of cancer drugs, researchers say.

HuR has been detected at high levels in almost every type of cancer tested, including cancers of the colon, prostate, breast, brain, ovaries, pancreas, and lung.

"HuR inhibitors may be useful for many types of cancer," says Liang Xu, associate professor of molecular biosciences at the University of Kansas. "Since HuR is involved in many stem cell pathways, we expect HuR inhibitors will be active in inhibiting ‘cancer stem cells,' or the seeds of cancer, which have been a current focus in the cancer drug discovery field."

HuR has been studied for many years, but until now no direct HuR inhibitors have been discovered.

"The initial compounds reported in this paper can be further optimized and developed as a whole new class of cancer therapy, especially for cancer stem cells," Xu says.

PRECISION MEDICINE
"The success of our study provides a first proof-of-principle that HuR is druggable, which opens a new door for cancer drug discovery. Many other RNA-binding proteins like HuR, which are so far undruggable, can also be tested for drug discovery using our strategy."

For the study, published in ACS Chemical Biology, researchers evaluated about 6,000 compounds from both the KU Chemical Methodologies and Library Development Center and the Food and Drug Administration in a process known as "high throughput screening," hunting for compounds that obstruct HuR's interface with healthy human RNA.

"A cancer-causing gene, or oncogene, makes RNA, which then makes an oncoprotein that causes cancer or makes cancer cells hard to kill, or both," Xu says. "This is the problem we're trying to overcome with precision medicine."

The HuR-RNA binding site is like a long, narrow groove, not a well-defined pocket seen in other druggable proteins targeted by many current cancer therapies.

"HuR tightly binds to RNA like a hand," Xu says. "The HuR protein grabs the ‘rope'-or the RNA-at a site called ‘ARE' on the rope. We aimed to find a small-molecule compound that makes the hand release the rope by competing with ARE of the RNA."

(Sources: University of Kansas; Futurity.org)
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
MAR 22, 2020
Cancer
MAR 22, 2020
What is "Shotgun ion mobility mass spectrometry sequencing"?
Research published recently in Nature Communications highlights a new method of mapping an essential family of polysacch ...
APR 12, 2020
Cancer
APR 12, 2020
Understanding the link between obesity and breast cancer
A researcher from the James Graham Brown Cancer Center at the University of Louisville claims to have figured out the mo ...
APR 14, 2020
Clinical & Molecular DX
APR 14, 2020
Urchin-shaped DNA Biosensor Detects Disease Earlier
For researchers at the Missouri University of Science and Technology developing a new class of nanodiagnostics, good thi ...
APR 19, 2020
Cancer
APR 19, 2020
Discovery of new biomarker detects urological cancer
New hope for the detection of urological cancers has been published in a study in the Journal of Extracellular Vesicles. ...
MAY 07, 2020
Cell & Molecular Biology
MAY 07, 2020
How the Function of a Critical Immune Cell is Related to Metabolism
This work suggests that it may be possible to dampen autoimmunity or promote an immune attack on cancer through a bioche ...
MAY 09, 2020
Cancer
MAY 09, 2020
Disney movies boost quality of life during chemo
Have you considered popping in a Disney movie during your next chemotherapy session? A study published recently in JAMA ...
Loading Comments...